Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ERAS ALERT: Securities Fraud Class Action Launched Against Erasca, Inc. - August 10, 2026 Deadline

accessnewswire.com
ERAS A securities fraud class action lawsuit has been filed against Erasca, Inc. alleging false statements and concealment related to preclinical data and patent/trade secret protections, impacting investor recovery. RVMD Mentioned as a point of comparison in a securities fraud lawsuit against Erasca, Inc. The article does not provide specific sentiment towards Revolution Medicines itself.

ERAS ALERT: Securities Fraud Class Action Launched Against Erasca, Inc. - August 10, 2026 Deadline NEW YORK CITY, NY / ACCESS Newswire / June 15, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ:ERAS) securities.

If you suffered a loss on your Erasca, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Erasca, Inc. Class Action or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.

THE LAWSUIT: A class action securities lawsuit was filed against Erasca, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 14, 2025 and April 26, 2026.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) ERAS-0015's preclinical data was based on improper comparisons to Revolution Medicines, Inc. ("RevMed") and placed Erasca at risk of violating patent and trade secret protections; and (2) based on the foregoing, defendants lacked a reasonable basis for their positive statements related to ERAS-0015.

WHAT'S NEXT? If you purchased Erasca, Inc. stock during the relevant time frame - even if you still hold your shares, learn about your rights to seek a recovery. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212)363-7500

Fax: (212) 363-7171

SOURCE: Levi & Korsinsky, LLP